Explore our global immunology and immunotoxicology capabilities, customizable to meet your needs: From early biomarker discovery and preclinical toxicology in a range of species, all the way through to early and late-stage clinical trials.

Give your device a healthy start by gaining the experienced and knowledgeable advice and specialized testing your device or combination product demands. Gain the insights and clarity you need to move forward with greater confidence.

The preclinical stage of medical device development comes with a unique set of challenges. You need to determine that the materials that make up your device are safe and biologically compatible and that your prototype will perform the way you intend.

Whether you need to test the materials your device is made of or the efficacy of your device or combination product, Labcorp offers the solutions and experience required to move forward with confidence.

Precision medicine, a new paradigm of individualized treatment, is revolutionizing healthcare.

This article discusses current opportunities in precision neurology, focusing on key biomarkers that help with the differential diagnosis of neurologic conditions as well as stratification of subjects for clinical trials focusing on Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and related disorders.

A wound is defined as an injury to a living tissue, most commonly skin. Wounds can be ulcerative, full thickness-due to some mechanically induced trauma-or caused by a burn.

In the current global climate, several companies that previously made commercial goods are now joining the call to produce masks, ventilators and other medical devices in short supply. This article will focus on the current U.S. environment.

ACS 2023 -- Analytical methods used to support the registration of products have to be effective, robust and reliable, meeting a range of specific requirements, as demonstrated during the validation process.

ACS 2023 -- Analytical chemists often face hurdles in developing reliable residue methods due to a range of scientific challenges. These can typically include poor instrument response, poor stability, unfavourable chemical properties, lack of selectivity or the need to quantify at very low concentrations.